Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hartmann

Showing results (141-150 of 265) with videos related to

Pageof 27
Sort By:
The American Journal of Surgical Pathology|October 15, 2013
Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal regionStephanie Heim, Rudi Beschorner, Michel Mittelbronn, et al.
Journal of the Neurological Sciences|September 6, 2021
Serum neurofilament light chain levels are associated with stroke severity and functional outcome in patients undergoing endovascular therapy for large vessel occlusionJan Rahmig, Katja Akgün, Erik Simon, et al.
Communications Biology|July 10, 2023
Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1Eva-Maria Thüring, Christian Hartmann, Janesha C Maddumage, et al.
Genes, Chromosomes & Cancer|June 10, 2005
Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiformeTeresita Díaz de Ståhl, Christian Hartmann, Cecilia de Bustos, et al.
International Journal of Cancer|January 26, 2012
Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomasBenito Campos, Rolf Warta, Jittiporn Chaisaingmongkol, et al.
EMBO Molecular Medicine|December 8, 2011
The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesisIris Augustin, Violaine Goidts, Angelika Bongers, et al.
Acta Neuropathologica Communications|October 19, 2019
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomasArne Christians, Antonia Adel-Horowski, Rouzbeh Banan, et al.
Neuro-Oncology|August 6, 2013
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylationWolfgang Wick, Joachim P Steinbach, Michael Platten, et al.
Plos One|October 19, 2012
Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseMartina Ott, Ulrike M Litzenburger, Felix Sahm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutationsChristian Hartmann, Bettina Hentschel, Matthias Simon, et al.
Pageof 27

Showing results (141-150 of 265) with videos related to

Sort By:
Pageof 27
The American Journal of Surgical Pathology|October 15, 2013
Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal regionStephanie Heim, Rudi Beschorner, Michel Mittelbronn, et al.
Journal of the Neurological Sciences|September 6, 2021
Serum neurofilament light chain levels are associated with stroke severity and functional outcome in patients undergoing endovascular therapy for large vessel occlusionJan Rahmig, Katja Akgün, Erik Simon, et al.
Communications Biology|July 10, 2023
Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1Eva-Maria Thüring, Christian Hartmann, Janesha C Maddumage, et al.
Genes, Chromosomes & Cancer|June 10, 2005
Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiformeTeresita Díaz de Ståhl, Christian Hartmann, Cecilia de Bustos, et al.
International Journal of Cancer|January 26, 2012
Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomasBenito Campos, Rolf Warta, Jittiporn Chaisaingmongkol, et al.
EMBO Molecular Medicine|December 8, 2011
The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesisIris Augustin, Violaine Goidts, Angelika Bongers, et al.
Acta Neuropathologica Communications|October 19, 2019
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomasArne Christians, Antonia Adel-Horowski, Rouzbeh Banan, et al.
Neuro-Oncology|August 6, 2013
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylationWolfgang Wick, Joachim P Steinbach, Michael Platten, et al.
Plos One|October 19, 2012
Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseMartina Ott, Ulrike M Litzenburger, Felix Sahm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutationsChristian Hartmann, Bettina Hentschel, Matthias Simon, et al.
Pageof 27